医疗保险支出增长:为什么近几十年来一直在放缓?
Angela Liu1, Klara K Lou1, Kathryn E Linehan1
11Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Annual review of public health
|December 18, 2025
概括
由于政策变化和经济因素,医疗保险支出增长放缓,尽管人口不断扩大. 这种适度可能会影响弱势受益者的获取和质量.
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
- 老年学是一门学科.
背景情况:
- 在过去的二十年中,医疗保险支出增长意外放缓.
- 尽管受益人数增加和医疗保险优势扩大,但这种放缓发生了.
- 预测没有预测医疗保健支出的这种缓和.
研究的目的:
- 确定导致医疗保险支出放缓的主要人口,政策和经济因素.
- 分析支付率调整,基于价值的护理计划和技术进步的作用.
- 探索未来的医疗保险支出预测和成本控制与受益人需求之间的平衡.
主要方法:
- 在过去20年中,对医疗保险支出趋势的分析.
- 审查政策影响,包括"平价医疗法案"和封存.
- 评估人口变化以及金融激励和医疗技术的影响.
主要成果:
- 由于多种因素,医疗保险支出增长显著放缓.
- 关键的驱动因素包括低支付率的增加,温和的人口变化和不断变化的金融激励措施.
- 基于价值的护理举措发挥了作用,尽管它们的确切影响很难量化.
结论:
- 医疗保险支出放缓,虽然在成本控制方面取得了成功,但可能会掩盖在医疗护理获取和质量的潜在权衡.
- 由于这些权衡,弱势群体可能面临未得到满足的需求.
- 未来的政策必须平衡金融可持续性与有效为高需求受益者提供服务的能力.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
181
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
181
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
Current Trends in Nursing I
5.2K
Current trends in nursing include:
5.2K


